{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=920&ordering=-name","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=880&ordering=-name","results":[{"accession":"CLO:0009294","name":"TE 170.M cell","definition":"['disease: fascia']","term_type":"cell line"},{"accession":"CLO:0009312","name":"TE16 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0009293","name":"TE 161.T cell","definition":"['disease: possible Burkitts lymphoma']","term_type":"cell line"},{"accession":"CLO:0009311","name":"TE15 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0009292","name":"TE 159.T cell","definition":"['disease: rhabdomyosarcoma']","term_type":"cell line"},{"accession":"CLO:0009291","name":"TE 149.T cell","definition":"['disease: leiomyosarcoma']","term_type":"cell line"},{"accession":"CLO:0009290","name":"TE 130.T cell","definition":"['disease: sacrococcygeal teratoma']","term_type":"cell line"},{"accession":"CLO:0009937","name":"TE-12 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0009289","name":"TE 125.T cell","definition":"['disease: rhabdomyosarcoma']","term_type":"cell line"},{"accession":"CLO:0009288","name":"TE 115.T cell","definition":"['disease: fibromatosis']","term_type":"cell line"},{"accession":"CLO:0009286","name":"T-D94 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0009285","name":"TD.1 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0009284","name":"TCMK-1 cell","definition":"[]","term_type":"cell line"},{"accession":"PR:000018337","name":"T-cell surface glycoprotein CD8 beta chain, signal peptide removed form","definition":"['A T-cell surface glycoprotein CD8 beta chain that has had the signal peptide removed.', 'Category=modification.']","term_type":"cell line"},{"accession":"PR:000025409","name":"T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed glycosylated form","definition":"['A T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed form that includes at least one glycosylated residue.', 'Category=modification.']","term_type":"cell line"},{"accession":"PR:000025407","name":"T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed form","definition":"['A T-cell surface glycoprotein CD8 beta chain isoform 1 that has had the signal peptide removed to yield the mature form.', 'Category=modification.']","term_type":"cell line"},{"accession":"PR:000025405","name":"T-cell surface glycoprotein CD8 beta chain isoform 1","definition":"['A T-cell surface glycoprotein CD8 beta chain that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P10966-1 or a 1:1 ortholog thereof.', 'Category=sequence.']","term_type":"cell line"},{"accession":"PR:000001085","name":"T-cell surface glycoprotein CD8 beta chain","definition":"['A protein that is a translation product of the human CD8B gene or a 1:1 ortholog thereof. CD8 is a transmembrane receptor that is a co-receptor for MHC class-I antigen/T-cell receptor interaction. The most common form of CD8 is composed of a CD8 alpha and a CD8 beta chain.', 'Category=gene.']","term_type":"cell line"},{"accession":"PR:000018335","name":"T-cell surface glycoprotein CD8 alpha chain, signal peptide removed form","definition":"['A T-cell surface glycoprotein CD8 alpha chain that has had the signal peptide removed.', 'Category=modification.']","term_type":"cell line"},{"accession":"PR:000025408","name":"T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed glycosylated form","definition":"['A T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed form that includes at least one glycosylated residue.', 'Category=modification.']","term_type":"cell line"}]}